Residency · Bethesda, MD
Sponsored by Clinical Center at the National Institutes of Health
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
Cancer cell · 2021 · 843 citations · John Minna
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Nature medicine · 2021 · 558 citations · Jonathan Kurie
Genome Sequencing for Diagnosing Rare Diseases.
The New England journal of medicine · 2024 · 161 citations · Carsten Bonnemann
Current clinical applications of AAV-mediated gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy · 2025 · 87 citations · Carsten Bonnemann
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.
Nature genetics · 2021 · 361 citations · Ellen Sidransky
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
JAMA · 2023 · 204 citations · David Beck
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.
Cancer cell · 2024 · 160 citations · John Minna
Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis.
Circulation · 2021 · 277 citations · Edward Fisher